Randomized open-label study of second-generation antipsychotics for the treatment of schizophrenia: 104-week final results of the JUMPs study assessing treatment discontinuation, remission, and social functioning
Randomized open-label study of second-generation antipsychotics for the treatment of schizophrenia: 104-week final results of the JUMPs study assessing treatment discontinuation, remission, and social functioning
Kazutaka Ohi, Nakao Iwata, Ken Inada, Taro Kishi et al.
Citations
2 citations
Journal
BMC Psychiatry
Topics
Schizophrenia research and treatment
Field-Weighted Citation Impact (FWCI)
0.77
article
Randomized open-label study of second-generation antipsychotics for the treatment of schizophrenia: 104-week final results of the JUMPs study assessing treatment discontinuation, remission, and social functioning
Omron (Japan) (JP), Akebono (Japan) (JP), Shizuoka City Shimizu Hospital (JP), National Center of Neurology and Psychiatry (JP), Kawamura Hospital (JP), Sapporo Minami Hospital (JP), Fujita Health University Hospital (JP), Akita University Hospital (JP), Tokyo Women's Medical University (JP), Noguchi Hospital (JP), Gifu Red Cross Hospital (JP), CNS Research (United States) (US), Gifu University (JP), Ehime University (JP), Kitasato University (JP), Nara Medical University (JP), Nara Institute of Science and Technology (JP), Tokushima University (JP)